Article

May 29, 2015

Dr Veena Shankaran Discusses Patient-Level Cancer Economics

Most of the research in cancer economics has been on total cost and cost effectiveness, which is why Veena Shankaran MD, MS, assistant professor in the division of medical oncology at the University of Washington, wanted to have a panel discussion on financial toxicity at the ISPOR 20th Annual Meeting.

Most of the research in cancer economics has been on total cost and cost effectiveness, which is why Veena Shankaran MD, MS, assistant professor in the division of medical oncology at the University of Washington, wanted to have a panel discussion on financial toxicity at the ISPOR 20th Annual Meeting.

The goal of the talk was to present strategies to measure financial burden and how to decrease the financial burden.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos

Merrill H. Stewart, MD

Nicolas Ferreyros, managing director, Community Oncology Alliance

Dr Ibrahim Aldoss

Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists

Rachel Rohaidy, MD

Mansi Shah, MD

Miriam Freimer, MD

Screenshot of Ivo Abraham, PhD, RN, during a video interview

Dr Pankit Vachhani

Dr Ibrahim Aldoss

Related Content

Analyzed by birth cohort, the authors found each successive birth cohort had a 7.7% decline in SCLC rates. | Image credit: shidlovski

June 29th 2025

Decline in SCLC Incidence Expected to Accelerate Through 2050

Jared Kaltwasser

The incidence of small cell lung cancer (SCLC) is projected to drop by 5.9% each year through 2050.

Managed Care Cast

June 24th 2025

Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care

Giuliana Grossi Skylar Jeremias Eva Szigethy, MD, PhD Benjamin Cohen, MD

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.

Hamlet Gasoyan, PhD

June 26th 2025

Improve Antiobesity Medication Adherence to Improve Results: Hamlet Gasoyan, PhD

Hayden E. Klein Hamlet Gasoyan, PhD

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic.

June 19th 2025

Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays

Maggie L. Shaw Colin Banas, MD, MHA

Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.

Gender rights | Image Credit: © Nadzeya-stock.adobe.com

June 23rd 2025

Culture Key to Data Collection of Sexual Orientation and Gender Identity in Cancer Care

This research highlights the key factors, like leadership buy-in, mandatory protocols, and electronic health record workflows, that influence the effective collection of data on sexual orientation and gender identity in outpatient oncology clinics to improve patient-centered care.

AJMC Q&A with Coral Omene, MD, PhD | Background image credit: ipopba - stock.adobe.com

June 22nd 2025

Addressing Cancer Care Challenges for Patients, and Ensuring Equity: Coral Omene, MD, PhD

Laura Joszt, MA Coral Omene, MD, PhD

Delivering value-based cancer care requires overcoming hurdles to access care and tailoring care that prioritizes the quality-of-life metrics the patient values, explained Coral Omene, MD, PhD.

Related Content

Analyzed by birth cohort, the authors found each successive birth cohort had a 7.7% decline in SCLC rates. | Image credit: shidlovski

June 29th 2025

Decline in SCLC Incidence Expected to Accelerate Through 2050

Jared Kaltwasser

The incidence of small cell lung cancer (SCLC) is projected to drop by 5.9% each year through 2050.

Managed Care Cast

June 24th 2025

Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care

Giuliana Grossi Skylar Jeremias Eva Szigethy, MD, PhD Benjamin Cohen, MD

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.

Hamlet Gasoyan, PhD

June 26th 2025

Improve Antiobesity Medication Adherence to Improve Results: Hamlet Gasoyan, PhD

Hayden E. Klein Hamlet Gasoyan, PhD

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic.

June 19th 2025

Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays

Maggie L. Shaw Colin Banas, MD, MHA

Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.

Gender rights | Image Credit: © Nadzeya-stock.adobe.com

June 23rd 2025

Culture Key to Data Collection of Sexual Orientation and Gender Identity in Cancer Care

This research highlights the key factors, like leadership buy-in, mandatory protocols, and electronic health record workflows, that influence the effective collection of data on sexual orientation and gender identity in outpatient oncology clinics to improve patient-centered care.

AJMC Q&A with Coral Omene, MD, PhD | Background image credit: ipopba - stock.adobe.com

June 22nd 2025

Addressing Cancer Care Challenges for Patients, and Ensuring Equity: Coral Omene, MD, PhD

Laura Joszt, MA Coral Omene, MD, PhD

Delivering value-based cancer care requires overcoming hurdles to access care and tailoring care that prioritizes the quality-of-life metrics the patient values, explained Coral Omene, MD, PhD.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions